Press Releases

Alfa Chemistry Materials Announces to Offer Molecular Sieve for Scientific Research

CPhI Pharma Index reaches record high as pharma confidence in growth rises in all markets

INFLAMMATIX AWARDED $1.7 MILLION GRANT FROM NATIONAL INSTITUTES OF HEALTH (NIH)

Inflammatix was awarded a $1.7 million grant from the National Institutes of Health (NIH) to support its development of a rapid diagnostic to identify immune subtypes (endotypes) of sepsis. Sepsis is a challenging disease with no available treatments, and the new test may enable endotype-specific therapies and/or the repurposing of available drugs to better treat sepsis.

Biotium expands multiplexing options for probe-based qPCR with unique red qPCR dye

Biotium has announced the release of EvaRuby™ Dye for qPCR and HRM®.

Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions

Thermo Fisher Scientific has announced a series of co-marketing agreements, in addition to a new chromatography system and acquisition, to support scientists in driving their proteomics research forwards.

Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry

BioPharma Dynamics has announced the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester

Alfa Chemistry Newly Adds Drinking Water Disinfection Byproducts Standards for Water Safety Research

UBIQUIGENT EXTENDS AND EXPANDS DRUG DISCOVERY COLLABORATION WITH BRISTOL MYERS SQUIBB

Ubiquigent has today announced the extension and expansion of its long-term collaboration with Bristol Myers Squibb.

The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

CD Formulation Offers Multiple Methods for Microbial Limit Test

LIQUID STABLE & READY-TO-USE TOTAL PROTEIN / ALBUMIN CLINICAL REFERENCE MATERIALS AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM offers an extensive line of combined Total Protein/Albumin clinical reference materials specifically designed and manufactured for the calibration and calibration verification of Albumin and Total Protein assays on a wide number of clinical testing systems, including those from Abbott Diagnostics, Beckman Coulter, Roche Diagnostics, Siemens Healthineers.

New Instant Inoculator™ QC Microorganisms Eliminate Prep Work and Simplify Microbiology Control Testing with One-Step Method

Stratix Labs has unveiled Instant Inoculator™ QC microorganisms, a novel, ready-to-use product that delivers reference microorganisms to solid media with a simple one-step method.

Panthera@theRutherford clinical trial partnership has commenced the first UK multicentre oncology trial in prostate cancer with ten more oncology trials in the pipeline

The first multisite oncology trial undertaken by the independent sector in the UK has started treating its first patient at the Rutherford Cancer Centre North East.

CMOs will account for four of the five top bio manufacturing capacities in 2025

230 Covid-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1000 vaccines in development

BIOFORTUNA DOUBLE THEIR MANUFACTURING CAPACITY

Biofortuna has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

The new global Rare Disease center of Emmes expects accelerating growth from US and European biotechs

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base

Christopher Flores, PhD Appointed as President and Chief Research and Development Officer of Doloromics, Inc.

Doloromics has announced the appointment of Dr. Chris Flores as their new President and Chief Research and Development Officer.

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York. Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease.